B. M. Trost and T. Zhang
Rh-catalyzed selective azirdination
(1S,5S,6R)-ethyl 5-(1,3-dioxoisoindolin-2-yl)-7-(2-(trimethylsilyl)ethylsul-
fonyl)-7-aza-bicyclo[4.1.0]hept-2-ene-3-carboxylate (44) : All glassware
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
was flamed dried under high vacuum. MgO was activated by flame-dry
under high vacuum before use. Chlorobenzene was distilled over P2O5
and stored under inert atmosphere over 4 ꢁ MS beads. Under a positive
pressure of N2, to SESNH2 in C6H5Cl (1 mL) was added sequentially mix-
ture 38 (149 mg, 0.5 mmol), MgO (46 mg, 1.15 mmol), [Rh
2ACHTUNGTRENNUNG(esp)2]
(7.6 mg, 0.01 mmol). The reaction was cooled to 08C. PhI(OPiv)2
ACHTUNGTRENNUNG
(264 mg, 0.65 mmol) was added in one portion. The reaction was slowly
warmed to RT and stirred for 4 h till the disappearance of 38 by TLC.
The MgO was filtered and washed thoroughly with CH2Cl2. The com-
bined filtrate was concentrated in vacuo with gentle heating and loaded
to a silica gel column. Eluting with 10:1 petroleum ether/ethyl acetate
yielded 44 as a white foam (206 mg, 86%). Rf =0.50 (2.5:1 petroleum
ether/ethyl acetate); m.p. 55–588C; [a]D =42.18 (CHCl3, c=1.08);
1H NMR (CDCl3, 500 MHz): d = 7.75
Scheme 30. Completion of the synthesis.
(dd, J=5.4, 3.1 Hz, 2H), 7.67 (dd, J=
5.5, 3.1 Hz, 2H), 7.15 (dd, J=4.5,
2.4 Hz, 1H), 4.90 (ddd, J=7.6, 3.5,
2.2 Hz, 1H), 4.14–4.07 (m, 2H), 3.47
(dd, J=6.6, 4.5 Hz, 1H), 3.40 (dt, J=
6.6, 1.7 Hz, 1H), 3.06–3.02 (m, 2H),
2.78 (dd, J=17.9, 3.3 Hz, 1H), 2.53
(ddd, J=17.7, 7.6, 2.6 Hz, 1H), 1.20 (t,
J=7.1 Hz, 3H), 1.04–1.00 (m, 2H),
0.005 ppm (s, 9H); 13C NMR (CDCl3,
125 MHz):
d = 167.5, 165.4, 134.3,
132.4, 131.4, 130.9, 123.3, 61.0, 49.2,
42.9, 40.3, 36.5, 26.1, 14.1, 9.5,
ꢀ2.1 ppm; IR (film): n˜ = 2955, 1775,
1715, 1468, 1388, 1327, 1263, 1144,
1109, 1005 cmꢀ1; HRMS: m/z: calcd
for C22H29N2O6SSi: 477.1516; found:
477.1494 [M+H]+.
Acknowledgements
Scheme 31. Final synthetic scheme.
We thank the National Institutes of
Health (GM 033049) and the National
Science Foundation for their generous
THF (70 mL) was injected into the flask and the mixture was stirred for
20 min at 408C to give a yellow solution. At 408C under N2, lactone 5
(2.48 g, 20 mmol) in 5 mL THF was cannulated into the solution. THF
(2ꢃ5 mL) was used to rinse the flask containing 8 and was also cannulat-
ed into the yellow solution. After 5 min, TMS-phthalimide (6.58 g,
30 mmol) in 15 mL THF was cannulated into the yellow solution under
N2. The reaction was then stirred at 408C under N2 for 8 h at which time
the TLC showed the disappearance of 8. THF was removed in vacuo. To
the residue was added TsOH·H2O (380 mg, 2.0 mmol) and 67 mL abso-
lute ethanol. The mixture was heated at reflux for 10 h monitored by
TLC. Ethanol was removed in vacuo, and the resulting solid mixture was
mixed evenly with 33 g silica gel by dissolving in CH2Cl2 and concentrat-
ing in vacuo. The silica gel containing crude product was loaded on top
of a silica gel column. Eluting with 15:1 petroleum ether/ethyl acetate
yielded 13 as a white solid (5.0 g, 84%). Rf =0.76 (1:1 petroleum ether/
ethyl acetate); HPLC OD 220 nm 90:10 heptane/2-propanol
0.8 mLminꢀ1, tmajor =11.44 min, tminor =15.54 min; [a]D =ꢀ93.88 (CHCl3,
c=1.05); m.p. 108–1128C; 1H NMR (CDCl3, 500 MHz): d = 7.75 (dd,
J=5.59, 3.07 Hz, 2H), 7.65 (dd, J=5.4, 3.1 Hz, 2H), 5.85 (m, 1H), 5.52
(d, 10.2, 1H), 4.92 (m, 1H), 4.07 (q, J=7.0 Hz, 2H), 2.72 (m, 1H), 2.34
(m, 2H), 2.27 (q, J=12.4 Hz, 1H), 2.13 (m, 1H), 1.18 ppm (t, J=7.6 Hz,
3H); 13C NMR (CDCl3, 125 MHz): d = 174.05, 167.8, 133.9, 131.9, 127.9,
126.6, 123.1, 60.5, 47.3, 39.4, 29.0, 27.0, 14.1 ppm; IR (neat): n˜ = 3033,
2984, 1770, 1731, 1702, 1613, 1464, 1387, 1179, 1105 cmꢀ1; elemental anal-
ysis calcd (%) for C17H17NO4: C, 68.21; H, 5.72; found: C, 67.88; H, 6.00;
HRMS: m/z: calcd for C17H17NO4: 299.1158; found: 299.1171 [M]+.
support of our programs. T.Z. thanks Novartis and Roche for graduate
fellowships. Mass spectra were provided, in part, by the Mass Spectrome-
try Regional Center of the University of California, San Francisco. Palla-
dium salts were generously supplied by Johnson-Matthey. We thank
Gilead Sciences for a reference sample of Tamiflu.
[1] For information on H5N1 avian flu and H5N1 virus, visit: http://
[2] For reviews on Tamiflu synthesis, see: a) V. Farina, J. D. Brown,
[3] Contributions from Gilead Sciences: a) C. U. Kim, W. Lew, M. A.
Williams, H. Liu, L. Zhang, S. Swaminathan, N. Bischofberger, M. S.
Chen, D. B. Mendel, C. Y. Tai, G. Laver, R. C. Stevens, J. Am.
tich, M. W. Becker, H. H. Chapman, D. E. Kelly, W. Lew, M. S.
Louie, L. R. McGee, E. J. Prisbe, L. M. Schultze, R. H. Yu, L.
Kim, W. Lew, H. Liu, M. A. Williams, US Patent 5763483, 1998. Ex-
tensive studies at Roche: d) S. Abrecht, P. Harrington, H. Iding, M.
3642
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 3630 – 3643